This trial will test whether or not receiving AMD genetic testing leads people to make healthier lifestyle choices as measured by their carotenoid status.
- Nutritional Biomarkers
- Genetic Testing
- Age-Related Macular Degeneration
2 Primary · 3 Secondary · Reporting Duration: Baseline and Month 12
Awards & Highlights
2 Treatment Groups
Late Genetic Results Disclosure
1 of 2
Early Genetic Results Disclosure
1 of 2
80 Total Participants · 2 Treatment Groups
Primary Treatment: Early disclosure of genetic testing results · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18 - 64 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has the FDA approved dispensing genetic test results prior to completion?
"With limited data on efficacy, but some evidence of safety, the Early disclosure of genetic testing results has been assigned a score of 2." - Anonymous Online Contributor
Are octogenarians being included in the enrollment process of this medical experiment?
"This research project is open to participants aged 18 and over, but below 64 years old." - Anonymous Online Contributor
What is the enrollment quota for this research study?
"Affirmative. According to the data on clinicaltrials.gov, this study is actively searching for participants and has been since August 3rd 2022. The most recent edit was made 8 days later, on August 10th 2022, with a requirement of 80 recruits from one location." - Anonymous Online Contributor
Who meets the eligibility criteria for participating in this clinical experiment?
"This research requires 80 participants of Caucasian heritage between 18 and 64 years old that have had genetic testing. It is not a requirement to show familial history of AMD, yet this could be beneficial for the study." - Anonymous Online Contributor
Is enrollment currently available for this research project?
"Affirmative. According to information found on clinicaltrials.gov, this experiment is actively recruiting participants who meet its criteria and was last updated August 10th 2022. A total of 80 patients are required from 1 medical centre for the trial's completion." - Anonymous Online Contributor